Literature DB >> 3873655

Polymorphism of normal factor IX detected by mouse monoclonal antibodies.

A Wallmark, R Ljung, I M Nilsson, L Holmberg, U Hedner, M Lindvall, H O Sjögren.   

Abstract

Hemophilia B is an X-chromosomal recessive disease due to deficiency of coagulation factor IX. Three monoclonal antibodies against factor IX were prepared and used to develop immunoradiometric assays (IRMAs) of factor IX antigen (IX-Ag). IX-Ag was measured in 65 normal individuals with one IRMA based on polyclonal anti-IX antibodies and two IRMAs based on three monoclonal anti-IX antibodies. One of the monoclonal antibodies differed in specificity since it neutralized less than 50% of the clotting activity of factor IX (IX-C), whereas the other two monoclonal antibodies neutralized 80-95%. When the former antibody was used as the solid phase in IRMA, two groups of normal individuals were distinguished: group A with measurable IX-Ag, and group B without demonstrable IX-Ag. There were no differences between the groups either in IX-C or in IX-Ag measured with polyclonal antibodies. A subgroup comprising only women could be distinguished in group A, in whom intermediate IX-Ag concentrations were found. Family studies showed the group B variant of normal factor IX to be transmitted according to the pattern of X-linked recessive inheritance. The allelic frequency of group A was 0.66, and that of group B was 0.34.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873655      PMCID: PMC397883          DOI: 10.1073/pnas.82.11.3839

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Variations in human serum beta-globulins.

Authors:  O SMITHIES
Journal:  Nature       Date:  1957-12-28       Impact factor: 49.962

2.  Agglutination of erythrocytes coated with incomplete anti-Rh by certain rheumatoid arthritic sera and some other sera; the existence of human serum groups.

Authors:  R GRUBB
Journal:  Acta Pathol Microbiol Scand       Date:  1956

Review 3.  The Pi system-inherited variants of serum alpha 1-antitrypsin.

Authors:  M K Fagerhol; C B Laurell
Journal:  Prog Med Genet       Date:  1970

4.  Regional localization on the human X chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus).

Authors:  G Camerino; K H Grzeschik; M Jaye; H De La Salle; P Tolstoshev; J P Lecocq; R Heilig; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

5.  The interaction of Ca2+ with human Factor IX.

Authors:  G W Amphlett; W Kisiel; F J Castellino
Journal:  Arch Biochem Biophys       Date:  1981-05       Impact factor: 4.013

6.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

7.  Activation of human factor IX (Christmas factor).

Authors:  R G Di Scipio; K Kurachi; E W Davie
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

8.  Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX.

Authors:  L Holmberg; B Gustavii; E Cordesius; A C Kristoffersson; R Ljung; L Löfberg; P Strömberg; I M Nilsson
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

9.  An investigation of three patients with Christmas disease due to an abnormal type of factor IX.

Authors:  K W Denson; R Biggs; P M Mannucci
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

10.  Monoclonal antibody specific for the mutant PiZ alpha 1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers.

Authors:  A Wallmark; R Alm; S Eriksson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more
  5 in total

1.  The varying frequencies of five DNA polymorphisms of X-linked coagulant factor IX in eight ethnic groups.

Authors:  J B Graham; G R Kunkel; N K Egilmez; A Wallmark; D M Fowlkes; S T Lord
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

2.  Direct estimate of the haemophilia B (factor IX deficiency) mutation rate and of the ratio of the sex-specific mutation rates in Sweden.

Authors:  A J Montandon; P M Green; D R Bentley; R Ljung; S Kling; I M Nilsson; F Giannelli
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

3.  Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies.

Authors:  I M Nilsson; E Berntorp; O Zettervall
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  The Malmö polymorphism of coagulation factor IX, an immunologic polymorphism due to dimorphism of residue 148 that is in linkage disequilibrium with two other F.IX polymorphisms.

Authors:  J B Graham; D B Lubahn; S T Lord; J Kirshtein; I M Nilsson; A Wallmark; R Ljung; L D Frazier; J L Ware; S W Lin
Journal:  Am J Hum Genet       Date:  1988-04       Impact factor: 11.025

5.  Two factor IX mutations in the family of an isolated haemophilia B patient: direct carrier diagnosis by amplification mismatch detection (AMD).

Authors:  A J Montandon; P M Green; D R Bentley; R Ljung; I M Nilsson; F Giannelli
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.